MSH2 and endometrial cancer: RRH at age 40 years has been demonstrated to prevent endometrial cancer by age 50 years in carriers of MLH1 (13%), MSH2 (16%)| and MSH6 (11%) GPVs who would have been expected to develop endometrial cancer [49].